(Q39576776)

13 September 2017

MTDH/AEG-1-based DNA vaccine suppresses lung metastasis and enhances chemosensitivity to doxorubicin in breast cancer (English)

1 reference

13 September 2017

1 reference

1 reference

Ben-Jiang Qian

1

1 reference

13 September 2017

Fei Yan

2

1 reference

13 September 2017

Na Li

3

1 reference

13 September 2017

Qiao-Ling Liu

4

1 reference

13 September 2017

Yi-Hui Lin

5

1 reference

13 September 2017

Chang-Ming Liu

6

1 reference

13 September 2017

Yun-Ping Luo

7

1 reference

13 September 2017

Fang Guo

8

1 reference

13 September 2017

Hui-Zhang Li

9

1 reference

13 September 2017

13 March 2011

1 reference

Cancer Immunology, Immunotherapy

13 September 2017

1 reference

13 September 2017

60

1 reference

13 September 2017

6

1 reference

13 September 2017

883-893

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-011-0997-3

13 September 2017

0 references

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Estimates of the lifetime direct costs of treatment for metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

DNA vaccines: precision tools for activating effective immunity against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

An autologous oral DNA vaccine protects against murine melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Astrocyte elevated gene-1: far more than just a gene regulated in astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Identification of genes conferring resistance to 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Molecular mechanism of chemoresistance by astrocyte elevated gene-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Astrocyte elevated gene-1: a novel target for human glioma therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Metadherin, a cell surface protein in breast tumors that mediates lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

The multifaceted role of MTDH/AEG-1 in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Oral somatic transgene vaccination using attenuated S. typhimurium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

DNA vaccines suppress tumor growth and metastases by the induction of anti-angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Plasmid DNA encoding human carcinoembryonic antigen (CEA) adsorbed onto cationic microparticles induces protective immunity against colon cancer in CEA-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Targeting tumor-associated macrophages as a novel strategy against breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Targeting HER-2/neu for active-specific immunotherapy in a mouse model of spontaneous breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Vaccination with the extracellular domain of p185neu prevents mammary tumor development in neu transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0997-3

10.1007/S00262-011-0997-3

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference